Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Passive Beat

ETF health check: testing the pulse of June 2016's hottest launches

A year on we reveal the ETFs that have seen assets swell as well as those that have failed to gain traction.

Four wealth managers on the role of ETFs

As exchange traded funds become an increasingly important cog in the investment wheel, we ask four wealth managers what role they play in their asset allocation.

ETF worries: capacity or liquidity?

The problem with capacity is you may get too large for the market; with liquidity that the market can move against you

Source launches Europe ex-UK ETF

In a response to the strengthening of European markets Source has launched a new Europe ex-UK exchange traded fund (ETF).

Lyxor slashes fees on European ETFs by more than 50%

Lyxor has the cut the fees on three of its Euro Stoxx exchange-traded funds (ETF) by over 50%.

Crazy in ETF love? New study imagines bottling star quality

Yes sir, they're cut from a different cloth, academics at the University of Zurich and MIT offer an alternative way to reach for the stars, passively.

Lyxor slashes fees on 10-strong sector ETF range

Lyxor cut the fee on its ten world sector exchange-traded fund (ETF).

Perfect blend: how seven DFMs mix active and passive strategies

We spoke to CIOs and heads of research to get an insight on their current positioning and how they blend passive and active strategies.

Invesco PowerShares lists US value ETF

The PowerShares S&P 500 QVM UCITS ETF will seek to replicate the S&P 500 quality, value & momentum multi-factor index.

Coombs: 'blunt tool' passive beta no use for risks ahead

David Coombs has come out firmly against passive investment calling it a ‘blunt tool’ and ‘riskier than active.’

Investment Trust video
Play IBT's Craig on the Trump impact for biotech

IBT's Craig on the Trump impact for biotech

Ailsa Craig of the International Biotechnology trust highlights the M&A activity seen in the biotechnology sector this year.

Comment